In ischemic stroke patients, both the frequency and immunosuppressive capacity of Tregs are significantly impaired, with the most profound decrease observed in the active CD39+FoxP3+ Treg subset [232]. This evidence concerns the gene ENTPD1 and ischemic stroke.